{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:16:59Z","timestamp":1794014219470,"version":"4.8.0"},"reference-count":10,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Frontline Gastroenterol"],"accepted":{"date-parts":[[2022,1,28]]},"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:p>The European Association for the Study of the Liver has recently published updated guidelines on the use of non-invasive tests to identify and stratify chronic liver disease. Here, we provide a summary of the key recommendations from the guideline.<\/jats:p>","DOI":"10.1136\/flgastro-2021-102064","type":"journal-article","created":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T13:30:59Z","timestamp":1644931859000},"page":"436-439","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":76,"title":["EASL clinical practice guidelines: non-invasive liver tests for evaluation of liver disease severity and prognosis"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4185-4454","authenticated-orcid":false,"given":"Ann J","family":"Archer","sequence":"first","affiliation":[{"name":"Liver Medicine, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK"},{"name":"Population Health Science, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine J","family":"Belfield","sequence":"additional","affiliation":[{"name":"Liver Medicine, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK"},{"name":"School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G","family":"Orr","sequence":"additional","affiliation":[{"name":"Liver Medicine, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona H","family":"Gordon","sequence":"additional","affiliation":[{"name":"Liver Medicine, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kushala WM","family":"Abeysekera","sequence":"additional","affiliation":[{"name":"Liver Medicine, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK"},{"name":"Population Health Science, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,2,15]]},"reference":[{"key":"2025090708572704000_13.5.436.1","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/S0140-6736(20)32396-5","article-title":"New dimensions for hospital services and early detection of disease: a review from the Lancet Commission into liver disease in the UK","volume":"397","author":"Williams","year":"2021","journal-title":"Lancet"},{"key":"2025090708572704000_13.5.436.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.04.006"},{"key":"2025090708572704000_13.5.436.3","doi-asserted-by":"crossref","unstructured":"Easl clinical practice guidelines (CpGs) on non-invasive tests for evaluation of liver disease severity and Prognosis- 2021 update. J Hepatol 2021;75.doi:10.1016\/j.jhep.2021.05.025","DOI":"10.1016\/j.jhep.2021.05.025"},{"key":"2025090708572704000_13.5.436.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.03.033"},{"key":"2025090708572704000_13.5.436.5","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2019-101177"},{"key":"2025090708572704000_13.5.436.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2029349"},{"key":"2025090708572704000_13.5.436.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.05.022"},{"key":"2025090708572704000_13.5.436.8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S2468-1253(20)30357-5","article-title":"Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis","volume":"6","author":"Petroff","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025090708572704000_13.5.436.9","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29085"},{"key":"2025090708572704000_13.5.436.10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cgh.2017.04.038","article-title":"Magnitude and Kinetics of Decrease in Liver Stiffness After Antiviral Therapy in Patients With Chronic Hepatitis C: A\u00a0Systematic Review and Meta-analysis","volume":"16","author":"Singh","year":"2018","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Frontline Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/flgastro-2021-102064","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T15:57:35Z","timestamp":1757260655000},"score":1,"resource":{"primary":{"URL":"https:\/\/fg.bmj.com\/lookup\/doi\/10.1136\/flgastro-2021-102064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,15]]},"references-count":10,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,8,5]]},"published-print":{"date-parts":[[2022,9]]}},"alternative-id":["10.1136\/flgastro-2021-102064"],"URL":"https:\/\/doi.org\/10.1136\/flgastro-2021-102064","relation":{},"ISSN":["2041-4137","2041-4145"],"issn-type":[{"value":"2041-4137","type":"print"},{"value":"2041-4145","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,15]]}}}